glutathione-s-transferase antibody development Frontiers Hepatocyte glutathione S-transferase mu 2
Description
acute liver failure study group: Lowering the risks of hepatic failure
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Gillies RJ, Pilot C, Marunaka Y, et al
Thereafter, improvisations on fluorescence-based methods such as measurement of skin autofluorescence to detect skin AGEs (Rabbani et al., 2016)
[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Jeong D., Dong G.-Z., Lee H.J., Ryu J.-H
